These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33646560)

  • 1. Association of urinary C-megalin with albuminuria and renal function in diabetes: a cross-sectional study (Diabetes Distress and Care Registry at Tenri [DDCRT 21]).
    Kurita N; Kinoshita M; Fujimura M; Kurosawa K; Sakuramachi Y; Takano K; Okamura S; Kitatani M; Tsujii S; Norton EC; Hayashino Y;
    J Nephrol; 2022 Jan; 35(1):201-210. PubMed ID: 33646560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between urinary C-megalin levels and progressive kidney dysfunction: a cohort study based on the diabetes distress and care registry at Tenri (DDCRT 24).
    Niihata K; Nishiwaki H; Kinoshita M; Kurosawa K; Sakuramachi Y; Matsunaga S; Okamura S; Tsujii S; Hayashino Y; Kurita N;
    Acta Diabetol; 2023 Dec; 60(12):1643-1650. PubMed ID: 37439857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary C-megalin as a novel biomarker of progression to microalbuminuria: A cohort study based on the diabetes Distress and Care Registry at Tenri (DDCRT 22).
    Nishiwaki H; Niihata K; Kinoshita M; Fujimura M; Kurosawa K; Sakuramachi Y; Takano K; Matsunaga S; Okamura S; Kitatani M; Tsujii S; Hayashino Y; Kurita N;
    Diabetes Res Clin Pract; 2022 Apr; 186():109810. PubMed ID: 35247529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of urinary tubule injury markers for predicting progression of renal dysfunction in patients with type 2 diabetes and albuminuria: The Fukuoka Diabetes Registry.
    Ide H; Iwase M; Ohkuma T; Fujii H; Komorita Y; Oku Y; Higashi T; Yoshinari M; Nakamura U; Kitazono T
    Diabetes Res Clin Pract; 2022 Apr; 186():109840. PubMed ID: 35331809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.
    Fu WJ; Xiong SL; Fang YG; Wen S; Chen ML; Deng RT; Zheng L; Wang SB; Pen LF; Wang Q
    Endocrine; 2012 Feb; 41(1):82-8. PubMed ID: 21779943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
    Jongs N; Greene T; Chertow GM; McMurray JJV; Langkilde AM; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Heerspink HJL;
    Lancet Diabetes Endocrinol; 2021 Nov; 9(11):755-766. PubMed ID: 34619106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble tumor necrosis factor receptor type 1 is an alternative marker of urinary albumin-creatinine ratio and estimated glomerular filtration rate for predicting the decline of renal function in subjects with type 2 diabetes mellitus.
    Chang LH; Chang TT; Chu CH; Huang CC; Lin LY
    Clin Chim Acta; 2024 May; 558():117880. PubMed ID: 38555050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between dipstick hematuria and decline in estimated glomerular filtration rate among Japanese patients with type 2 diabetes: A prospective cohort study [Diabetes Distress and Care Registry at Tenri (DDCRT 14)].
    Mashitani T; Hayashino Y; Okamura S; Kitatani M; Furuya M; Iburi T; Tsujii S; Ishii H;
    J Diabetes Complications; 2017 Jul; 31(7):1079-1084. PubMed ID: 28499960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary cystatin C as a biomarker of early renal dysfunction in type 2 diabetic patients.
    Hassan M; Hatata EZ; Al-Arman M; Aboelnaga MM
    Diabetes Metab Syndr; 2021; 15(4):102152. PubMed ID: 34186366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary A- and C-megalin predict progression of diabetic kidney disease: an exploratory retrospective cohort study.
    Iida T; Hosojima M; Kabasawa H; Yamamoto-Kabasawa K; Goto S; Tanaka T; Kitamura N; Nakada M; Itoh S; Ogasawara S; Kaseda R; Suzuki Y; Narita I; Saito A
    J Diabetes Complications; 2022 Nov; 36(11):108312. PubMed ID: 36228564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease.
    Di Marco M; Scilletta S; Miano N; Marrano N; Natalicchio A; Giorgino F; Di Mauro S; Filippello A; Scamporrino A; Tribulato P; Bosco G; Di Giacomo Barbagallo F; Scicali R; Milluzzo A; Ballirò T; Frittitta L; Castellino P; Purrello F; Piro S; Di Pino A
    Cardiovasc Diabetol; 2023 Dec; 22(1):344. PubMed ID: 38093293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stronger Association of Albuminuria with the Risk of Vascular Complications than Estimated Glomerular Filtration Rate in Type 2 Diabetes.
    Hong X; Huang L; Zhang Y; Shen X; Weng S; Zeng F; Zhao F; Yan S
    Kidney Blood Press Res; 2021; 46(5):550-562. PubMed ID: 34428770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2.
    Maeda Y; Suzuki A; Ishii J; Sekiguchi-Ueda S; Shibata M; Yoshino Y; Asano S; Hayakawa N; Nakamura K; Akiyama Y; Kitagawa F; Sakuishi T; Fujita T; Hashimoto S; Ozaki Y; Itoh M
    Heart Vessels; 2015 May; 30(3):362-8. PubMed ID: 24626813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and validation of the cut-off values of estimated glomerular filtration rate and urinary albumin-to-creatinine ratio for diabetic kidney disease: A multi-center, prospective cohort study.
    Gao Z; Zhu Y; Sun X; Zhu H; Jiang W; Sun M; Wang J; Liu L; Zheng H; Qin Y; Zhang S; Yang Y; Xu J; Yang J; Shan C; Chang B
    Front Endocrinol (Lausanne); 2022; 13():1064665. PubMed ID: 36578951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine Albumin-Creatinine Ratio Variability in People With Type 2 Diabetes: Clinical and Research Implications.
    Rasaratnam N; Salim A; Blackberry I; Cooper ME; Magliano DJ; van Wijngaarden P; Varadarajan S; Sacre JW; Shaw JE
    Am J Kidney Dis; 2024 Jul; 84(1):8-17.e1. PubMed ID: 38551531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-grade albuminuria is associated with early but not late carotid atherosclerotic lesions in community-based patients with type 2 diabetes.
    Li MF; Tu YF; Li LX; Lu JX; Dong XH; Yu LB; Zhang R; Bao YQ; Jia WP; Hu RM
    Cardiovasc Diabetol; 2013 Jul; 12():110. PubMed ID: 23883448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in urinary albumin as a surrogate for kidney disease progression in people with type 2 diabetes.
    Yokoyama Y; Hanai K; Mori T; Yamamoto Y; Yoshida N; Murata H; Shinozaki T; Babazono T
    Clin Exp Nephrol; 2023 May; 27(5):465-472. PubMed ID: 36840900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.
    Żyłka A; Dumnicka P; Kuśnierz-Cabala B; Gala-Błądzińska A; Ceranowicz P; Kucharz J; Ząbek-Adamska A; Maziarz B; Drożdż R; Kuźniewski M
    Mediators Inflamm; 2018; 2018():7659243. PubMed ID: 30158836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can both normal and mildly abnormal albuminuria and glomerular filtration rate be a danger signal for diabetic peripheral neuropathy in type 2 diabetes mellitus?
    Zhang Y; Jiang Y; Shen X; Yan S
    Neurol Sci; 2017 Aug; 38(8):1381-1390. PubMed ID: 28478497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary megalin in association with progression factors of diabetic nephropathy.
    Akour A; Kasabri V; Bulatova N; Al-Motassem Y; Fahmawi H; Momani M; Zayed A; Alquoqa R; AlHawari H
    Bratisl Lek Listy; 2019; 120(7):532-535. PubMed ID: 31602990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.